Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
M.D. Anderson Cancer Center Musculoskeletal Transplant Foundation |
---|---|
Information provided by: | M.D. Anderson Cancer Center |
ClinicalTrials.gov Identifier: | NCT00632294 |
Primary Objectives:
Condition | Intervention |
---|---|
Bone Cancer |
Procedure: Tissue Sample |
Study Type: | Observational |
Study Design: | Case-Only, Retrospective |
Official Title: | Retrieved Allograft Study: Retrospective Study of the Biomechanical Properties of Large Allografts |
A leftover sample of the removed allograft bone will be collected and used to learn about the properties (such as bone strength, bone density, and new bone formation) of the removed transplant tissue.
Estimated Enrollment: | 200 |
Study Start Date: | December 2007 |
Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
Retrieved Allograft
Patients that require the retrieval of a bone allograft (transplant).
|
Procedure: Tissue Sample
A leftover sample of the removed allograft bone will be collected.
|
Allograft Surgery:
As a standard of care, you will be having surgery to remove allograft tissue that has failed or because there were other complications following your earlier transplant. You will be separately consented for this surgery, which will describe the procedure and its risks in detail.
Tissue Research:
If you agree to take part in this study, leftover sample of the removed allograft bone will be collected and used to learn about the properties (such as bone strength, bone density, and new bone formation) of the removed transplant tissue. This tissue will be stored at the University of Arkansas for use in this study. Any remaining leftover tissue will be destroyed by the end of December 2011.
Data Collection:
Before you have surgery, you will have an x-ray. This is also part of standard of care. If you take part in this study, this x-ray will be used to learn about the properties of the transplant tissue.
All other information will be coming from your medical record, either from your past visits or as a result of your surgery. The information being collected will include information about your graft during the time it was within your body and observations made by your surgeon at its removal.
Length of Study:
Your participation in this study will be over after your tissue and data are collected.
This is an investigational study. Up to 200 patients will be enrolled on this multicenter study. Up to 20 will be enrolled at M. D. Anderson.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patients that require the retrieval of a bone allograft (transplant).
Inclusion Criteria:
Exclusion Criteria:
Contact: Susan Banner, BS | 713-745-4117 |
United States, Texas | |
U.T.M.D. Anderson Cancer Center | Recruiting |
Houston, Texas, United States, 77030 | |
Principal Investigator: Valerae O. Lewis, MD |
Principal Investigator: | Valerae O. Lewis, MD | U.T.M.D. Anderson Cancer Center |
Responsible Party: | U.T.M.D. Anderson Cancer Center ( Valerae O. Lewis, MD/Associate Professor ) |
Study ID Numbers: | 2007-0689 |
Study First Received: | February 4, 2008 |
Last Updated: | July 31, 2009 |
ClinicalTrials.gov Identifier: | NCT00632294 History of Changes |
Health Authority: | United States: Institutional Review Board |
Bone Cancer Allograft Retrieval Allograft Bone Bone Mineral Density |
Musculoskeletal Diseases Bone Neoplasms Bone Diseases |
Neoplasms Neoplasms by Site Musculoskeletal Diseases Bone Neoplasms Bone Diseases |